Growth hormone secretagogue receptor‐1a mediates ghrelin's effects on attenuating tumour‐induced loss of muscle strength but not muscle mass

Abstract

Ghrelin may ameliorate cancer cachexia (CC) by preventing anorexia, muscle, and fat loss. However, the mechanisms mediating these effects are not fully understood. This study characterizes the pathways involved in muscle mass and strength loss in the Lewis lung carcinoma (LLC)‐induced cachexia model, and the effects of ghrelin in mice with or without its only known receptor: the growth hormone secretagogue receptor‐1a ((GHSR‐1a), Ghsr+/+ and Ghsr−/−).

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 15, 2021
Source ID
10.1002/jcsm.12743

Entities

People

  • Alison Tewnion
  • Anthony Christiani
  • Barbara Anderson
  • Beatrice A. Breckheimer
  • Brynn Irwin
  • Haiming M Liu
  • Ian (in‐gi) Lee
  • José M. Garcia
  • Kora Krumm
  • Lena Strait‐bodey
  • Mackenzie Storie
  • Pu Zang
  • Theresa Li

Organizations

  • Congressionally Directed Medical Research Programs
  • National Institutes of Health
  • United States Department of Veterans Affairs
  • University of Washington

Tags

Fields of Study

  • Biology

Readers

  • Cardiovascular Physiology
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Molecular Biology and Genetics